FlexCAre: Flexible Care Delivery Model for Arthritis
Start date:
2023
End date:
December 2027
Overview
The goal of this study is to find out what is important to you when it comes to follow-up and continued care delivery of your inflammatory rheumatic disease. The information we collect will help inform a team of scientists, clinicians, patients, community and supporting partners who are designing new ways to deliver care.
What will be done?
Participating in the FlexCAre Discrete Choice Experiment online survey involves completing an online survey that takes 20-25 minutes to complete. In the survey, you will be asked questions about yourself, your experience with inflammatory rheumatic disease(s), and your preferences for inflammatory rheumatic disease care. The survey includes a series of hypothetical questions about inflammatory arthritis care delivery models for you to make decisions about.
Who can participate?
YOU MAY BE ELIGIBLE IF YOU:
- Are 19 years and up.
- Have a diagnosis of inflammatory rheumatic disease(s).
- Can complete a survey in English
If you would like to determine if you are eligible for this study, please click here to contact the study team.
Want to find out more?
If you have any questions, please do not hesitate to contact the Flexcare study team here.
This study is being conducted by researchers at the University of British Columbia (UBC H23-00930) in collaboration with Arthritis Research Canada.
This study is funded by Canadian Institutes of Health Research and The Arthritis Society.
Flexcare Study Team
Dr. Diane Lacaille (MDCM, MHSc, FRCPC)
Principal Investigator for FLexCAre Study
Mary Pack Chair in Rheumatology Research
Scientific Director, Arthritis Research Canada/Arthrite-Recherche Canada
Professor, Division of Rheumatology, University of British Columbia
